Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis [Corrigendum]

Ullah A, Chen G, Hussain A, et al. Int J Nanomedicine. 2021;16:4451–4470. The authors have advised there is an error in the author list on page 4451. The text “Muhammad Usman,6” should read “Muhammad Usman,8”. The authors apologize for this error. Re...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ullah A, Chen G, Hussain A, Khan H, Abbas A, Zhou Z, Shafiq M, Ahmad S, Ali U, Usman M, Raza F, Ahmed A, Qiu Z, Zheng M, Liu D
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	polyethyleneimine cyclam gene delivery liver fibrosis cxcr4 Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/c458089d5cec41c6af75368f27972975
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Cyclam-Modified Polyethyleneimine for Simultaneous TGF&beta; siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis [Corrigendum]

Ejemplares similares

Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis [Corrigendum]